News & Press Releases

Mintz advised the underwriters in connection with Eupraxia Pharmaceuticals’ $63.2 million public offering.

Mintz advised Vercept, a Seattle-based computer-use AI startup, in its sale to Anthropic, the leading AI safety and research company developing frontier-scale models and best known for its Claude family of large language models (LLMs). 

Mintz advised global investment firm Sixth Street in connection with its $500 million strategic financing facility with Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing.  

Mintz is pleased to announce that five Attorneys have been named ‘Top Authors’ in their respective fields by JD Supra in its 2026 Readers’ Choice Awards. This annual award recognizes top authors and firms for their thought leadership in key topics and reaching high levels of visibility and engagement.

Mintz is pleased to welcome Tung-On (T.O.) Kong, who has joined the firm as a Member in its Intellectual Property Division. A nationally recognized life sciences patent strategist, T.O. brings more than two decades of trial and appellate experience representing pharmaceutical, biotechnology, medical device, and diagnostics companies in bet-the-company disputes.

World Intellectual Property Review (WIPR) USA Patents Ranking 2025 edition highlights the firms that handle the most consequential matters in the US and that have developed patent portfolios for some of the world’s biggest companies.